| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |